Biol Reprod
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


BOR - Papers in Press, published online ahead of print August 6, 2003.
Biol Reprod 2003, 10.1095/biolreprod.103.019620
This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/6/1957    most recent
biolreprod.103.019620v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Hirsch, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Hirsch, E.
Agricola
Right arrow Articles by Wang, H.
Right arrow Articles by Hirsch, E.
BIOLOGY OF REPRODUCTION 69, 1957–1963 (2003)
DOI: 10.1095/biolreprod.103.019620
© 2003 by the Society for the Study of Reproduction, Inc.


Pregnancy

Bacterially-Induced Preterm Labor and Regulation of Prostaglandin-Metabolizing Enzyme Expression in Mice: The Role of Toll-Like Receptor 41

Hao Wang, and Emmet Hirsch2

Department of Obstetrics and Gynecology, Evanston Northwestern Healthcare, Feinberg School of Medicine, Northwestern University, Evanston, Illinois 60201


    ABSTRACT
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Toll-like receptor 4 (TLR-4) is a critical mediator of the cellular response to lipopolysaccharide. Our purpose was to examine the role of TLR-4 in parturition and in the regulation of expression of prostaglandin synthase (cyclooxygenase [COX]-1 and COX-2) and 15-hydroxyprostaglandin dehydrogenase (PGDH) following exposure to heat-killed Escherichia coli (HKE) in pregnant mice. Inbred TLR-4-mutant C3H/HeJ mice and inbred normal C3HeB/FeJ mice on Day 14.5 of a 19- to 20-day gestation received intrauterine injection of either HKE or sterile vehicle (PBS). Preterm or term delivery was recorded for these animals. Tissues (myometrium, decidual caps, placentas, fetal membranes, and fetuses) were collected after injection of sterile vehicle or 5 x 109 HKE bacteria (n = 5 mice per strain per treatment per time point). The COX-1, COX-2, and PGDH gene expression was determined by semiquantitative reverse transcription-polymerase chain reaction. We found that 5 x 109 HKE induced preterm delivery in 100% of TLR-4-normal mice but in 0% of TLR-4-mutant mice. The HKE exposure up-regulated expression of COX-2, but not of COX-1, in maternal tissues in both mouse strains. The prostaglandin-catabolizing enzyme PGDH was down-regulated in myometrium, fetal membranes, and fetuses in control mice, but no change was observed in TLR-4-mutant mice after HKE treatment. These results demonstrate that a functional TLR-4 is essential for HKE-induced preterm labor and PGDH down-regulation but is not essential for HKE-induced COX-2 gene up-regulation. The TLR-4 may mediate bacterially induced preterm labor via regulation of prostaglandin degradation rather than prostaglandin synthesis.

gene regulation, parturition, pregnancy uterus


    INTRODUCTION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Preterm birth occurs in 5–10% of all pregnancies and accounts for 70–75% of early neonatal morbidity and mortality [1]. Approximately 30–40% of preterm births are associated with an underlying infectious process. Systemic and local intrauterine infections have been implicated in the pathogenesis of preterm labor and delivery [2, 3]. Indeed, either local or systemic exposure to microbial products leads to preterm birth in several animal models [48]. However, the signaling pathways leading from the inciting inflammatory stimulus to labor after bacterial exposure remain incompletely defined.

Prostaglandins stimulate uterine contractions and cervical ripening during labor. Both prostaglandin E2 (PGE2) and prostaglandin F2{alpha} (PGF2{alpha}) are produced by maternal and fetal tissues during parturition, and the concentration of both increases in the amniotic fluid during labor [9]. Administration of prostaglandin synthase inhibitors suppresses uterine activity and prolongs the length of pregnancy [10]. Primary prostaglandins are formed from arachidonic acid through activity of the cyclooxygenase (COX) enzyme complex. The COX catalyzes the first committed step of prostaglandin synthesis, the initial conversion of arachidonic acid to PGH2. Two isoforms of COX have been identified, COX-1 and COX-2, which are also known as prostaglandin endoperoxide H synthase (PGHS)-1 and PGHS-2, respectively. The COX-1 is constitutively expressed in many tissues with little regulation in synthesis, whereas COX-2 is inducible in response to a variety of growth factors and inflammatory stimuli. Mice lacking the gene for PGF2{alpha} receptor [11] or COX-1 [12] have delayed onset of labor because of the roles of these factors in regulating luteolysis and myometrial expression of oxytocin receptors. Recent studies demonstrate a dramatic increase of COX-1, but not of COX-2, transcripts and activity in the uterus [13] and fetal membranes [14] in mice during late gestation. In one report, both COX-1 and COX-2 expression within the uterus were significantly altered within 2 h of lipopolysaccharide (LPS) administration, with COX-2 increasing and COX-1 decreasing [15].

The NAD+-dependent 15-hydroxyprostaglandin dehydrogenase (PGDH) is responsible for the initial inactivation of prostaglandins, catalyzing the conversion of primary prostaglandins to their biologically inactive 15-keto derivatives. Expression and activity of PGDH have been demonstrated in fetomaternal tissues of different species. Reduced PGDH expression and activity in myometrium and chorion have been suggested in association with term and preterm birth in humans [9]. However, in the mouse, PGDH mRNA increased in placentas and fetal membranes [16] and decreased in uterus [13] during late gestation. These studies suggest that COX and PGDH in the fetomaternal environment may play important roles in the initiation of labor, but the relative contributions of the maternal and the fetal tissues to COX and PGDH activity during infection are still incompletely defined.

We have reported a model of infection-induced preterm birth in mice following intrauterine inoculation with live or heat-killed Escherichia coli (HKE). Intrauterine inoculation of pregnant CD-1 mice with HKE on Day 14.5 of a 19- to 20-day gestation leads to dose-dependent preterm delivery. This process mimics human infection-associated preterm labor in many important ways, such as the expression of proinflammatory cytokines [1719]. We have demonstrated significant increases in interleukin (IL)-1, IL-6, and tumor necrosis factor (TNF) within uteri and fetal membranes following HKE treatment in this mouse model [19], as has been demonstrated in humans. However, several groups have shown that blockade of IL-1 and/or TNF by using IL-1-receptor antagonist, soluble TNF-receptor Fc fusion protein, or IL-1 and IL-1-receptor knockout mice does not prevent preterm delivery in mice after administration of bacteria or LPS [2022]. Thus, it remains uncertain whether inflammatory cytokines are critical mediators of the signals by which bacterial exposure causes labor.

A gram-negative bacterial cell wall component, LPS can induce expression of inflammatory cytokines and prostaglandins and leads to preterm birth in pregnant mice [6, 8] and rats [23] following intraperitoneal injection or intrauterine infusion. The current consensus is that LPS signaling occurs through a heterotrimeric receptor complex, of which the toll-like receptor 4 (TLR-4) protein is a critical component. A point mutation in the intracytoplasmic region of TLR-4 is responsible for the 20- to 40-fold LPS hyporesponsiveness of C3H/HeJ mice [24]. The defective Lps allele affects the functions of several cell types, including the macrophage, which on activation normally secretes a large array of proinflammatory factors and is critical for the innate immune response to bacterial pathogens.

In the present study, we used inbred pregnant C3HeB/FeJ mice (TLR-4-normal) and C3H/HeJ (TLR-4-mutant) mice to test the hypothesis that E. coli induces preterm labor via TLR-4 and to characterize the role of TLR-4 in the fetal and maternal expression of prostaglandin metabolic enzymes during the early phase of bacterially induced preterm labor.


    MATERIALS AND METHODS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Animals

All animals were treated in accordance with the Guide for Care and Use of Laboratory Animals and with the approval of the Animal Care and Use Committee of Evanston Northwestern Healthcare and Northwestern University. Inbred C3HeB/FeJ mice and C3H/HeJ mice (Jackson Laboratory, Bar Harbor, ME) were housed at an ambient temperature of 72°F and a 12L:12D photoperiod. Animals had free access to food and water. Females (age, 8–14 wk) were mated with fertile males. Mating was verified by the presence of a vaginal plug. On Day 14.5 after plugging (~75% of the typical 19- to 20-day gestation), surgery was performed (see below).

Preparation of HKE

Escherichia coli bacteria (American Type Culture Collection no. 12014) were grown to log phase at 37°C in Luria-Bertani broth (Invitrogen, Carlsbad, CA) and concentrated by centrifugation. They were then washed three times with phosphate-buffered saline (PBS) and suspended in PBS. Serial dilutions of the E. coli suspension were plated in triplicate to determine the concentration of bacteria by overnight culture. Immediately after plating these dilutions, the E. coli within the PBS suspension were killed by boiling in water for 5 min, and the suspension was then frozen at -20°C. Bacterial killing was verified by lack of growth overnight in broth and solid media. After the concentration of the bacterial suspension was determined, the HKE stock was thawed and diluted to a concentration of 1 x 1010 organisms/ml. This latter suspension was vortexed, aliquoted, and frozen at -80°C. Before each experiment, one of the frozen killed bacterial aliquots was thawed, vortexed, and diluted as necessary to the desired concentration.

Inoculation procedure and specimens

Pregnant mice were anesthetized with 16–18 µg/g body weight of a mixture of 2.5% (w/v) tribromoethyl alcohol and 2.5% (v/v) tert-amyl alcohol (Aldrich Chemical, Milwaukee, WI) in PBS. A 1.5-cm midline incision was made in the lower abdomen, and 100 L of pyrogen-free PBS or HKE suspended in PBS were injected into the midsection of the right uterine horn at a site between two adjacent fetuses. The abdominal incision was then closed in two layers using interrupted 5-0 coated vicryl sutures through the peritoneum and staples at the skin.

To establish the dose-response relationship between bacterial exposure and preterm delivery, a group of 40 pregnant C3HeB/FeJ (TLR-4-normal) mice and 20 pregnant C3H/HeJ (TLR-4-mutant) mice were monitored after inoculation of variable amounts of HKE. These animals underwent twice-daily observations in which health status was recorded. Mice that delivered prematurely (defined as the finding of at least one pup in the cage or the lower vagina within 48 h of surgery) or delivered at term underwent autopsy when fetuses were found in the cage. Some mice not delivered prematurely underwent autopsy 72 h after surgery to determine fetal status.

For measurement of COX and PGDH transcripts within fetomaternal tissues, a second group of pregnant C3HeB/FeJ and C3H/HeJ mice were inoculated with either pyrogen-free PBS or HKE sufficient to cause preterm delivery in 100% of C3HeB/FeJ mice (5 x 109 organisms). Animals were killed with carbon dioxide gas, and tissues were collected at 0, 1, 2, and 4 h after surgery for C3HeB/FeJ mice or at 4 h after surgery for C3H/HeJ mice (5 animals per group per time point). Harvest times early during the course of infection were selected, because previous data showed that levels of cytokines, enzymes, and transcription factors change in myometrium in CD-1 mice within 4 h of inoculation with high-dose HKE [18]. The abdomen was opened, and the injected uterine horn was cut away from its mesometrium and then incised longitudinally along the antimesenteric border. The gestational sacs and placentas were shelled out, and the right uterine horns were then washed in ice-cold PBS. The decidual cap at each implantation site was removed by sharp dissection, leaving behind the myometrium. The individual sacs surrounding each fetus were cut away, and fetus, fetal membranes, and placentas were washed in cold PBS. These specimens were then minced and immediately frozen in liquid nitrogen. Decidual caps, fetal membranes, placentas, and fetuses were pooled by tissue for each pregnancy.

RNA extraction

Total RNA was extracted from tissue specimens after homogenization in TRIzol reagent (Invitrogen, Carlsbad, CA) according to the manufacturer's instructions. The quantity and quality of the RNA was verified by spectrophotometry and formaldehyde gel electrophoresis, respectively.

Reverse Transcription-Polymerase Chain Reaction

Five to eight micrograms of total RNA were used as a template for cDNA synthesis. The cDNA was prepared using random primers and the Moloney murine leukemia virus reverse transcriptase system (Invitrogen). Polymerase chain reaction (PCR) primers were designed and synthesized on the basis of reported mouse cDNA sequences for COX-1, COX-2, PGDH, and ß-actin. Sequences of the primers and amplicon lengths were as follows: for COX-1, 5'-gcatgtggctgtggatgtca-3' (forward) and 5'-ggtcttggtgttgaggcaga-3' (reverse), with an amplicon of 388 base pairs (bp) corresponding to nucleotides 1395–1782 in the mouse COX-1 cDNA (GenBank accession no. BC005573.1); for COX-2, 5'-acactctatcactggcaccc-3' (forward) and 5'-gaagggacaccccttcacat-3' (reverse), with an amplicon of 585 bp corresponding to nucleotides 1229–1813 in the mouse COX-2 cDNA (GenBank accession no. NM011198.1); for PGDH, 5'-atttcggaagattggatattttggtc-3' (forward) and 5'-ttcaatgagatctattaatccattgg-3' (reverse), with an amplicon of 461 bp corresponding to nucleotides 269–729 in the mouse PGDH cDNA (GenBank accession no. NM008278.1); and for ß-actin, 5'-attgtgatggactccggtgacgg-3' (forward) and 5'-atcttgatcttcatggtgctagg-3' (reverse), with an amplicon of 536 bp corresponding to nucleotides 373–908 in the mouse ß-actin cDNA (GenBank accession no. M12481.1). Each PCR reaction was performed in a 30-µl mixture containing 1.0 µl of cDNA, 10 pmol of each primer, 0.25 mM dNTP, and 1.25 U of Taq DNA polymerase (Roche Applied Science, Indianapolis, IN). Cycling conditions were as follows: denaturation for 40 sec at 94°C, annealing for 30 sec at 62°C, and extension for 60 sec at 72°C. After sequencing of COX-1, COX-2, PGDH, and ß-actin PCR products to confirm the gene specificity of these fragments, the optimal number of amplification cycles was determined in pilot reactions and were as follows: 22 cycles for ß-actin, 28 cycles for COX-1, 30 cycles for COX-2, and 38 cycles for PGDH.

After amplification, the PCR products were resolved by 1.2% agarose gel electrophoresis and visualized by staining with SYBR green-1 (Molecular Probes, Eugene, OR). Cycle numbers were determined empirically to yield amplicon bands of moderate intensity that represented a linear relationship between the number of cycles and the logarithm of the number of target molecules. The density of each DNA band was evaluated with a STORM-860 PhosphorImager and analyzed using the ImageQuantTM software package (both from Molecular Dynamics, Sunnyvale, CA) as reported previously [25]. The ratios of the signals for COX-1, COX-2, and PGDH to that of ß-actin were used as to determine the relative level of transcription expression. We have shown that ß-actin levels remain relatively stable within gestational tissues following HKE exposure in our mouse model over at least 4 h (unpublished data).

Statistical Analysis

All values in the figures and text are expressed as the mean ± SEM. Data sets were examined by one-way analysis of variance, and individual group means were compared with the Student unpaired t-test. For preterm delivery or fetal death, chi-square analyses was used with the Fisher exact correction when necessary. Differences between groups were considered to be significant when P < 0.05.


    RESULTS
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
Dose-Response Relationship between HKE and Incidence of Preterm Delivery in TLR-4-Normal (C3HeB/FeJ) Mice

Six of six LPS-sensitive C3HeB/FeJ mice treated with vehicle delivered normal litters at term. Intrauterine injection of HKE demonstrated a dose-response relationship between inoculum size and incidence of preterm delivery (Table 1). Administration of the higher inocula (5 x 109 or 1 x 1010 bacteria) resulted in 100% preterm delivery within an average of 17.5 h after surgery. All offspring delivered preterm were dead. Among animals treated with the lower HKE inocula, intrauterine demise was observed in 20% of fetuses exposed to 1 x 107 bacteria (48 live fetuses and 12 dead fetuses in a total of six mothers killed on Day 3 after surgery) and in 55% exposed to 1 x 108 bacteria (17 live fetuses and 21 dead fetuses in a total of four mothers killed on Day 3 after surgery). In general, animals that were administered a delivery inoculum at or below 5 x 109 organisms appeared to be healthy or mildly ill (exhibiting mild piloerection, decreased mobility, and anorexia). Recovery after delivery appeared to be complete in most cases. The HKE inoculation at a dose of 1 x 1010 organisms caused maternal death or severe illness requiring five of six mice to be killed.


View this table:
[in this window]
[in a new window]
 
TABLE 1. Relationship between inoculum size of HKE and incidence of preterm delivery in C3HeB/FeJ (normal) and C3H/HeJ (TLR-4-mutant) mice treated on Day 14.5 of 20-day gestation.a

Effect of TLR-4 on Bacterially Induced Preterm Delivery

To test the hypothesis that HKE induces preterm delivery via TLR-4, C3H/HeJ (TLR-4-mutant) mice were inoculated with quantities of HKE sufficient to cause preterm delivery in 100% of control C3HeB/FeJ mice. As shown in Table 1, preterm delivery occurred in none of eight TLR-4-mutant mice after treatment with 5 x 109 HKE and in two of seven after treatment with 1 x 1010 HKE. Among TLR-4-mutant mice treated with HKE, intrauterine demise was observed in 7% of fetuses exposed to 5 x 109 bacteria (26 live fetuses and two dead fetuses in a total of five mothers killed on Day 3 after surgery) and in 34% exposed to 1 x 1010 bacteria (23 live fetuses and 12 dead fetuses in a total of five mothers killed on Day 3 after surgery). Maternal illness was not seen with 5 x 109 bacteria and was only mild with 1 x 1010 bacteria.

Effects of HKE on COX-1, COX-2, and PGDH Transcripts in Maternal and Fetal Tissues

To determine whether transcription of the rate-limiting enzymes of prostaglandin synthesis (COX-1, COX-2, and PGDH) is regulated via TLR-4 during the early phase of bacterially induced preterm labor, semiquantitative reverse transcription-PCR was performed in pregnancy tissues obtained within 4 h after administration of either PBS or 5 x 109 HKE. In both mouse strains, bacterial exposure caused significant increases in COX-2 mRNA in myometrium and decidual caps but not in placentas and fetuses (Figs. 13). After HKE treatment, COX-2 mRNA becomes higher in maternal tissues (myometrium and decidual caps) than in fetal tissues in C3HeB/FeJ (normal) mice but not in C3H/HeJ (LPS-resistant) mice (Fig. 3). Basal levels of COX-1 mRNA in maternal tissues are higher than in fetal tissues in C3H/HeJ mice but not in C3HeB/FeJ mice. Levels of COX-1 remained unchanged in all tested maternal and fetal tissues in both strains (Figs. 1, 2, and 4).



View larger version (29K):
[in this window]
[in a new window]
 
FIG. 1. Expression of COX-1 and COX-2 transcripts in maternal tissues of C3HeB/FeJ (TLR-4-normal) mice receiving PBS (Control) or HKE. The COX-1, COX-2, and ß-actin transcripts were detected by RT-PCR. Typical gels are shown (A). Ratios of the relative signal intensities of COX-1/ß-actin (B) and COX-2/ß-actin (C) in myometrium and decidual caps (n = 5 in each group) are depicted. *P < 0.05 compared with the value of vehicle-treated controls



View larger version (20K):
[in this window]
[in a new window]
 
FIG. 3. Comparison of COX-2 transcripts in fetomaternal tissues of normal (C3HeB/FeJ) and TLR-4-mutant (C3H/HeJ) mice 4 h after HKE injection. For purposes of standardization, all ratios are expressed as fold-change from the baseline measurement in control fetuses. *P < 0.05 compared with the value of vehicle-treated controls for the same tissue type



View larger version (28K):
[in this window]
[in a new window]
 
FIG. 2. Expression of COX-1 and COX-2 transcripts in fetal tissues of C3HeB/FeJ (TLR-4-normal) mice receiving PBS (Control) or HKE. The COX-1, COX-2, and ß-actin transcripts were detected by reverse transcription-PCR. Typical gels are shown (A). Ratios of the relative signal intensities of COX-1/ß-actin (B) and COX-2/ß-actin (C) in placentas, fetal membranes, and fetuses (n = 5 in each group) are depicted. *P < 0.05 compared with the value of vehicle-treated controls



View larger version (23K):
[in this window]
[in a new window]
 
FIG. 4. Comparison of COX-1 transcripts in fetomaternal tissues of normal (C3HeB/FeJ) and TLR-4-mutant (C3H/HeJ) mice 4 h after HKE injection. For purposes of standardization, all ratios are expressed as fold-change from the baseline measurement in control fetuses. No significant differences are present between the two treatment groups

In normal (C3HeB/FeJ) mice, basal levels of PGDH were detectable but were lower in maternal tissues (myometrium and decidual caps) than in fetal tissues (Fig. 5). Levels of PGDH decreased significantly after HKE treatment in fetuses, fetal membranes, and myometrium, respectively, compared to those after control injections. In decidual caps, however, PGDH mRNA increased over its low basal level. In TLR-4-mutant (C3H/HeJ) mice, basal levels of PGDH were detectable in fetal tissues but not in maternal tissues (Fig. 5). Levels of PGDH remained unchanged in fetal tissues after HKE treatment.



View larger version (21K):
[in this window]
[in a new window]
 
FIG. 5. Comparison of PGDH transcripts in fetomaternal tissues of normal (C3HeB/FeJ) and TLR-4-mutant (C3H/HeJ) mice 4 h after HKE injection. The PGDH and ß-actin transcripts were detected by reverse transcription-PCR. Typical gels are shown (upper panels) as well as quantitative analysis of relative signal intensities of PGDH/ß-actin ((lower panels); n = 5 in each group). *P < 0.05 compared with the value of vehicle-treated controls


    DISCUSSION
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 
The present study demonstrates that TLR-4 is a critical mediator of labor signals in the murine bacterial infection model. Although HKE induces premature delivery in normal mice in a dose-dependent manner, this phenomenon does not occur, or is greatly obtunded, in TLR-4-mutant mice. The small effect observed with very high numbers of HKE may be caused either by residual signaling via the mutant TLR-4 or other receptors or by bacterial factors other than LPS. Parallel observations were also made in relation to maternal illness and fetal demise resulting from bacterial exposure. We have previously demonstrated that fetal death per se in the absence of a bacterial stimulus does not result in labor in the mouse [19].

What is the mechanism by which bacteria cause labor? Previous studies have suggested a central role for prostaglandins and their synthetic and catabolic enzymes in this process. Variable reports have appeared concerning changes in COX expression at parturition in different species and in different circumstances. In the mouse, increased COX-1, but not COX-2, mRNA was reported during late gestation in the uterus [13] and fetal membranes [14], with increased COX-2 expression during term labor as well as ethanol- and LPS-induced preterm labor [26, 27]. In the rat, one study found that both COX-1 and COX-2 increased in myometrium with the onset of labor [28], but a different study reported increased expression of COX-2 only [29]. In sheep, increased COX-2 expression in endometrium, placenta, and myometrium was tightly associated with the onset of betamethasone-induced premature labor as well as spontaneous term labor [30]. In the baboon, COX-2 expression was increased in the lower uterine segment, cervix, and decidua but not in the uterine fundus, chorion, and placenta during late pregnancy and labor [31]. In humans, a large increase in COX-2 mRNA was found throughout late gestation in fetal tissues [32]. Both COX-1 and COX-2 have been reported to decrease or remain unchanged in the myometrium at the onset of labor [33] and to increase in the amnion during term labor [34].

The present results show that the levels of COX-2 transcripts in myometrium and decidua increase sharply in response to HKE treatment in both C3HeB/FeJ and C3H/HeJ mice, whereas COX-1 mRNA levels remain unchanged in the tissues tested for both mouse strains. These data suggest that TLR-4 signaling may not be essential for bacterially induced COX-2 gene expression, and they support the notion that COX-2, not COX-1, is the enzyme primarily responsible for increased prostaglandin biosynthesis during bacterially induced preterm labor. Several studies have shown that COX-2 antagonism may inhibit preterm labor in different species, such as human [35], sheep [36], rat [37], and mice [15, 38]. This conclusion is also supported by other data, such as a report that pretreatment of pregnant mice with COX-2 inhibitor, but not COX-1 inhibitor, prevented LPS-induced preterm labor [15].

To our knowledge, this is the first study to report that the basal levels of PGDH mRNA in mid- to late-pregnancy mice are higher in fetal tissues (fetus, fetal membranes, and placenta) than in maternal uterine tissues in both C3HeB/FeJ and C3H/HeJ mice. This tissue distribution of PGDH may allow for finely controlled regulation of prostaglandin activity in individual tissues during pregnancy. After HKE treatment, PGDH mRNA decreases significantly in the fetus, fetal membranes, and myometrium in TLR-4-normal mice but not in TLR-4 mutant mice. These data suggest that TLR-4 signaling may be involved in HKE-induced PGDH down-regulation. The role of prostaglandins generated in the fetus itself during gestation is still not clear. When the fetus is infected, fetal cortisol, cytokine, and prostaglandin production are increased [39, 40]. The currently accepted hypothesis is that PGDH represents a metabolic barrier in fetal tissues, either to prevent the passage of prostaglandins generated in these tissues to the uterus or to prevent prostaglandins generated in other tissues from damaging the fetus. During HKE-induced preterm labor, this functional barrier may break down, perhaps accounting for the fetal inflammatory response that has been observed during infection [40, 41].

In summary, the present study suggests that TLR-4 signaling is a critical factor in bacterially induced preterm labor. During bacterially induced preterm labor, TLR-4 signaling mediates PGDH gene down-regulation but is not essential for COX-2 gene up-regulation. Bacterially induced prostaglandin activity may be mediated primarily by increased synthesis in maternal tissues and decreased degradation in fetal tissues.


    ACKNOWLEDGMENTS
 
The authors thank Yana Filipovich for technical assistance.


    FOOTNOTES
 
1 Supported by a grant from March of Dimes (6-FY99-908) and NIH (1RO1HD41689). Back

2 Correspondence: Emmet Hirsch, Department of Obstetrics and Gynecology, Evanston Northwestern Healthcare, 2650 Ridge Avenue, Evanston, IL 60201. FAX: 847 733 5083; e-hirsch{at}northwestern.edu Back

Received: 28 May 2003.

First decision: 14 June 2003.

Accepted: 6 August 2003.


    REFERENCES
 TOP
 ABSTRACT
 INTRODUCTION
 MATERIALS AND METHODS
 RESULTS
 DISCUSSION
 REFERENCES
 

  1. Challis JR, Smith SK. Fetal endocrine signals and preterm labor. Biol Neonate 2001 79:163-167[CrossRef][Medline]
  2. Romero R, Mazor M, Wu YK, Sirtori M, Oyarzun E, Mitchell MD, Hobbins JC. Infection in the pathogenesis of preterm labor. Semin Perinatol 1988 12:262-279[Medline]
  3. Goldenberg RL, Hauth JC, Andrews WW. Intrauterine infection and preterm delivery. N Engl J Med 2000 342:1500-1507[Free Full Text]
  4. McDuffie RS Jr, Sherman MP, Gibbs RS. Amniotic fluid tumor necrosis factor-{alpha} and interleukin-1 in a rabbit model of bacterially induced preterm pregnancy loss. Am J Obstet Gynecol 1992 167:1583-1588[Medline]
  5. Gravett MG, Witkin SS, Haluska GJ, Edwards JL, Cook MJ, Novy MJ. An experimental model for intraamniotic infection and preterm labor in rhesus monkeys. Am J Obstet Gynecol 1994 171:1660-1667[Medline]
  6. Fidel PL Jr, Romero R, Wolf N, Cutright J, Ramirez M, Araneda H, Cotton DB. Systemic and local cytokine profiles in endotoxin-induced preterm parturition in mice. Am J Obstet Gynecol 1994 170:1467-1475[Medline]
  7. Hirsch E, Saotome I, Hirsh D. A model of intrauterine infection and preterm delivery in mice. Am J Obstet Gynecol 1995 172:1598-1603[CrossRef][Medline]
  8. Kaga N, Katsuki Y, Obata M, Shibutani Y. Repeated administration of low-dose lipopolysaccharide induces preterm delivery in mice: a model for human preterm parturition and for assessment of the therapeutic ability of drugs against preterm delivery. Am J Obstet Gynecol 1996 174:754-759[CrossRef][Medline]
  9. Patel FA, Challis JR. Prostaglandins and uterine activity. Front Horm Res 2001 27:31-56[Medline]
  10. Jeyabalan A, Caritis SN. Pharmacologic inhibition of preterm labor. Clin Obstet Gynecol 2002 45:99-113[CrossRef][Medline]
  11. Sugimoto Y, Yamasaki A, Segi E, Tsuboi K, Aze Y, Nishimura T, Oida H, Yoshida N, Tanaka T, Katsuyama M, Hasumoto K, Murata T, Hirata M, Ushikubi F, Negishi M, Ichikawa A, Narumiya S. Failure of parturition in mice lacking the prostaglandin F receptor. Science 1997 277:681-683[Abstract/Free Full Text]
  12. Gross GA, Imamura T, Luedke C, Vogt SK, Olson LM, Nelson DM, Sadovsky Y, Muglia LJ. Opposing actions of prostaglandins and oxytocin determine the onset of murine labor. Proc Natl Acad Sci U S A 1998 95:11875-11879[Abstract/Free Full Text]
  13. Winchester SK, Imamura T, Gross GA, Muglia LM, Vogt SK, Wright J, Watanabe K, Tai HH, Muglia LJ. Coordinate regulation of prostaglandin metabolism for induction of parturition in mice. Endocrinology 2002 143:2593-2598[Abstract/Free Full Text]
  14. Gupta DK, Sato TA, Keelan JA, Marvin KW, Mitchell MD. Expression of prostaglandin H synthase-1 and -2 in murine intrauterine and gestational tissues from mid pregnancy until term. Prostaglandins Other Lipid Mediat 2001 66:17-25[CrossRef][Medline]
  15. Gross G, Imamura T, Vogt SK, Wozniak DF, Nelson DM, Sadovsky Y, Muglia LJ. Inhibition of cyclooxygenase-2 prevents inflammation-mediated preterm labor in the mouse. Am J Physiol Regul Integr Comp Physiol 2000 278:R1415-R1423[Abstract/Free Full Text]
  16. Sato TA, Gupta DK, Keelan JA, Marvin KW, Mitchell MD. Cytosolic phospholipase A2and 15-hydroxyprostaglandin dehydrogenase mRNA expression in murine uterine and gestational tissues during late pregnancy. Prostaglandins Leukot Essent Fatty Acids 2001 64:247-251[CrossRef][Medline]
  17. Hirsch E, Blanchard R, Mehta SP. Differential fetal and maternal contributions to the cytokine milieu in a murine model of infection-induced preterm birth. Am J Obstet Gynecol 1999 180:429-434[CrossRef][Medline]
  18. Muhle RA, Pavlidis P, Grundy WN, Hirsch E. A high-throughput study of gene expression in preterm labor with a subtractive microarray approach. Am J Obstet Gynecol 2001 185:716-724[CrossRef][Medline]
  19. Mussalli GM, Blanchard R, Brunnert SR, Hirsch E. Inflammatory cytokines in a murine model of infection-induced preterm labor: cause or effect?. J Soc Gynecol Investig 1999 6:188-195[CrossRef][Medline]
  20. Reznikov LL, Fantuzzi G, Selzman CH, Shames BD, Barton HA, Bell H, McGregor JA, Dinarello CA. Utilization of endoscopic inoculation in a mouse model of intrauterine infection-induced preterm birth: role of interleukin 1beta. Biol Reprod 1999 60:1231-1238[Abstract/Free Full Text]
  21. Fidel PL Jr, Romero R, Cutright J, Wolf N, Gomez R, Araneda H, Ramirez M, Yoon BH. Treatment with the interleukin-I receptor antagonist and soluble tumor necrosis factor receptor Fc fusion protein does not prevent endotoxin-induced preterm parturition in mice. J Soc Gynecol Investig 1997 4:22-26[CrossRef][Medline]
  22. Hirsch E, Muhle RA, Mussalli GM, Blanchard R. Bacterially induced preterm labor in the mouse does not require maternal interleukin-1 signaling. Am J Obstet Gynecol 2002 186:523-530[CrossRef][Medline]
  23. Bennett WA, Terrone DA, Rinehart BK, Kassab S, Martin JN Jr, Granger JP. Intrauterine endotoxin infusion in rat pregnancy induces preterm delivery and increases placental prostaglandin F2{alpha} metabolite levels. Am J Obstet Gynecol 2000 182:1496-501[CrossRef][Medline]
  24. Beutler B, Poltorak A. Positional cloning of LPS, and the general role of toll-like receptors in the innate immune response. Eur Cytokine Netw 2000 11:2143-152[Medline]
  25. Wang H, Tan X, Chang H, Gonzalez-Crussi F, Remick DG, Hsueh W. Regulation of platelet-activating factor receptor gene expression in vivo by endotoxin, platelet-activating factor and endogenous tumour necrosis factor. Biochem J 1997 322:603-608
  26. Cook JL, Zaragoza DB, Sung DH, Olson DM. Expression of myometrial activation and stimulation genes in a mouse model of preterm labor: myometrial activation, stimulation, and preterm labor. Endocrinology 2000 141:1718-1728[Abstract/Free Full Text]
  27. Swaisgood CM, Zu HX, Perkins DJ, Wu S, Garver CL, Zimmerman PD, Iams JD, Kniss DA. Coordinate expression of inducible nitric oxide synthase and cyclooxygenase-2 genes in uterine tissues of endotoxin-treated pregnant mice. Am J Obstet Gynecol 1997 177:1253-1262[CrossRef][Medline]
  28. Dong YL, Gangula PR, Fang L, Yallampalli C. Differential expression of cyclooxygenase-1 and -2 proteins in rat uterus and cervix during the estrous cycle, pregnancy, labor and in myometrial cells. Prostaglandins 1996 52:13-34[CrossRef][Medline]
  29. Arslan A, Zingg HH. Regulation of COX-2 gene expression in rat uterus in vivo and in vitro. Prostaglandins 1996 52:463-481[CrossRef][Medline]
  30. Wu WX, Ma XH, Yoshizato T, Shinozuka N, Nathanielsz PW. Increase in prostaglandin H synthase 2, but not prostaglandin F2{alpha} synthase, mRNA in intrauterine tissues during betamethasone-induced premature labor and spontaneous term labor in sheep. J Soc Gynecol Investig 2001 8:69-76[CrossRef][Medline]
  31. Wu WX, Ma XH, Smith GC, Koenen SV, Nathanielsz PW. A new concept of the significance of regional distribution of prostaglandin H synthase 2 throughout the uterus during late pregnancy: investigations in a baboon model. Am J Obstet Gynecol 2000 183:1287-1295[CrossRef][Medline]
  32. Olson DM, Mijovic JE, Zaragoza DB, Cook JL. Prostaglandin endoperoxide H synthase type 1 and type 2 messenger ribonucleic acid in human fetal tissues throughout gestation and in the newborn infant. Am J Obstet Gynecol 2001 184:169-174[CrossRef][Medline]
  33. Giannoulias D, Patel FA, Holloway AC, Lye SJ, Tai HH, Challis JR. Differential changes in 15-hydroxyprostaglandin dehydrogenase and prostaglandin H synthase (types I and II) in human pregnant myometrium. J Clin Endocrinol Metab 2002 87:1345-1352[Abstract/Free Full Text]
  34. Mijovic JE, Zakar T, Angelova J, Olson DM. Prostaglandin endoperoxide H synthase mRNA expression in the human amnion and decidua during pregnancy and in the amnion at preterm labour. Mol Hum Reprod 1999 5:182-187[Abstract/Free Full Text]
  35. Stika CS, Gross GA, Leguizamon G, Gerber S, Levy R, Mathur A, Bernhard LM, Nelson DM, Sadovsky Y. A prospective randomized safety trial of celecoxib for treatment of preterm labor. Am J Obstet Gynecol 2002 187:653-660[CrossRef][Medline]
  36. Scott JE, Grigsby PL, Hirst JJ, Jenkin G. Inhibition of prostaglandin synthesis and its effect on uterine activity during established premature labor in sheep. J Soc Gynecol Investig 2001 8:266-276[CrossRef][Medline]
  37. Okawa T, Suzuki H, Yaanagida K, Sato A, Vedernikov Y, Saade G, Garfield R. Effect of lipopolysaccharide on uterine contractions and prostaglandin production in pregnant rats. Am J Obstet Gynecol 2001 184:84-89[CrossRef][Medline]
  38. Sakai M, Tanebe K, Sasaki Y, Momma K, Yoneda S, Saito S. Evaluation of the tocolytic effect of a selective cyclooxygenase-2 inhibitor in a mouse model of lipopolysaccharide-induced preterm delivery. Mol Hum Reprod 2001 7:595-602[Abstract/Free Full Text]
  39. Yoon BH, Romero R, Jun JK, Maymon E, Gomez R, Mazor M, Park JS. An increase in fetal plasma cortisol but not dehydroepiandrosterone sulfate is followed by the onset of preterm labor in patients with preterm premature rupture of the membranes. Am J Obstet Gynecol 1998 179:1107-1114[CrossRef][Medline]
  40. Romero R, Gomez R, Ghezzi F, Yoon BH, Mazor M, Edwin SS, Berry SM. A fetal systemic inflammatory response is followed by the spontaneous onset of preterm parturition. Am J Obstet Gynecol 1998 179:186-193[CrossRef][Medline]
  41. Chaiworapongsa T, Romero R, Kim JC, Kim YM, Blackwell SC, Yoon BH, Gomez R. Evidence for fetal involvement in the pathologic process of clinical chorioamnionitis. Am J Obstet Gynecol 2002 186:1178-1182[CrossRef][Medline]



This article has been cited by other articles:


Home page
Am. J. Pathol.Home page
W. Wang, H. Yen, C.-H. Chen, R. Soni, N. Jasani, G. Sylvestre, and S. E. Reznik
The Endothelin-Converting Enzyme-1/Endothelin-1 Pathway Plays a Critical Role in Inflammation-Associated Premature Delivery in a Mouse Model
Am. J. Pathol., October 1, 2008; 173(4): 1077 - 1084.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
A. W Horne, S. J Stock, and A. E King
Innate immunity and disorders of the female reproductive tract
Reproduction, June 1, 2008; 135(6): 739 - 749.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
K. Koga and G. Mor
Review Article: Expression and Function of Toll-Like Receptors at the Maternal--Fetal Interface
Reproductive Sciences, March 1, 2008; 15(3): 231 - 242.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
V. M. Abrahams
Antagonizing Toll-like Receptors to Prevent Preterm Labor
Reproductive Sciences, February 1, 2008; 15(2): 108 - 109.
[PDF]


Home page
Mol. Endocrinol.Home page
J. D. Roizen, M. Asada, M. Tong, H.-H. Tai, and L. J. Muglia
Preterm Birth without Progesterone Withdrawal in 15-Hydroxyprostaglandin Dehydrogenase Hypomorphic Mice
Mol. Endocrinol., January 1, 2008; 22(1): 105 - 112.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
V. Ilievski, S.-J. Lu, and E. Hirsch
Activation of Toll-like Receptors 2 or 3 and Preterm Delivery in the Mouse
Reproductive Sciences, May 1, 2007; 14(4): 315 - 320.
[Abstract] [PDF]


Home page
Biol. Reprod.Home page
K. N. Evans, L. Nguyen, J. Chan, B. A. Innes, J. N. Bulmer, M. D. Kilby, and M. Hewison
Effects of 25-Hydroxyvitamin D3 and 1,25-Dihydroxyvitamin D3 on Cytokine Production by Human Decidual Cells
Biol Reprod, December 1, 2006; 75(6): 816 - 822.
[Abstract] [Full Text] [PDF]


Home page
Am. J. Pathol.Home page
X. Wang, H. Hagberg, C. Mallard, C. Zhu, M. Hedtjarn, C.-F. Tiger, K. Eriksson, A. Rosen, and B. Jacobsson
Disruption of Interleukin-18, but Not Interleukin-1, Increases Vulnerability to Preterm Delivery and Fetal Mortality after Intrauterine Inflammation
Am. J. Pathol., September 1, 2006; 169(3): 967 - 976.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
M. Breuiller-Fouche and G. Germain
Gene and protein expression in the myometrium in pregnancy and labor.
Reproduction, May 1, 2006; 131(5): 837 - 850.
[Abstract] [Full Text] [PDF]


Home page
ReproductionHome page
B. Zhao, D. Koon, and K. E Bethin
Identification of transcription factors at the site of implantation in the later stages of murine pregnancy.
Reproduction, March 1, 2006; 131(3): 561 - 571.
[Abstract] [Full Text] [PDF]


Home page
NeoReviewsHome page
J. D. Roizen and L. J. Muglia
Understanding the Timing of Birth: The Continuing Challenge to Prevent Prematurity
NeoReviews, March 1, 2006; 7(3): e151 - e159.
[Full Text] [PDF]


Home page
ReproductionHome page
T. M Lindstrom and P. R Bennett
The role of nuclear factor kappa B in human labour
Reproduction, November 1, 2005; 130(5): 569 - 581.
[Abstract] [Full Text] [PDF]


Home page
Reproductive SciencesHome page
R. Romero, O. Erez, and J. Espinoza
Intrauterine Infection, Preterm Labor, and Cytokines
Reproductive Sciences, October 1, 2005; 12(7): 463 - 465.
[PDF]


Home page
Reproductive SciencesHome page
K. Yoshimura and E. Hirsch
Effect of Stimulation and Antagonism of Interleukin-1 Signaling on Preterm Delivery in Mice
Reproductive Sciences, October 1, 2005; 12(7): 533 - 538.
[Abstract] [PDF]


Home page
Reproductive SciencesHome page
E. Hirsch and H. Wang
The Molecular Pathophysiology of Bacterially Induced Preterm Labor: Insights From the Murine Model
Reproductive Sciences, April 1, 2005; 12(3): 145 - 155.
[Abstract] [PDF]


Home page
Proc. Natl. Acad. Sci. USAHome page
J. C. Condon, P. Jeyasuria, J. M. Faust, and C. R. Mendelson
Surfactant protein secreted by the maturing mouse fetal lung acts as a hormone that signals the initiation of parturition
PNAS, April 6, 2004; 101(14): 4978 - 4983.
[Abstract] [Full Text] [PDF]


This Article
Right arrow Abstract Freely available
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
69/6/1957    most recent
biolreprod.103.019620v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Wang, H.
Right arrow Articles by Hirsch, E.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Wang, H.
Right arrow Articles by Hirsch, E.
Agricola
Right arrow Articles by Wang, H.
Right arrow Articles by Hirsch, E.


HOME <